We are live on ! Find out more
QTTB icon

Q32 Bio
QTTB

39 hedge funds and large institutions have $126M invested in Q32 Bio in 2024 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 5 increasing their positions, 14 reducing their positions, and 30 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,000% more capital invested

Capital invested by funds: $11.4M → $126M (+$114M)

228.24% more ownership

Funds ownership: 1.8% → 230.04% (+228%)

32% less funds holding

Funds holding: 57 → 39 (-18)

57% less first-time investments, than exits

New positions opened: 13 | Existing positions closed: 30

64% less repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 14

Holders
39
Holders Change
-18
Holders Change %
-31.58%
% of All Funds
0.56%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.03%
New
13
Increased
5
Reduced
14
Closed
30
Calls
$197K
Puts
–
Net Calls
+$197K
Net Calls Change
+$176K

Top Buyers

Rank Fund Capital Flow
1
O
OrbiMed
New York
+$31M
2
AVLSA
Atlas Venture Life Science Advisors
Massachusetts
+$28.8M
3
CG
Carlyle Group
District of Columbia
+$15.2M
4
VC
Vivo Capital
California
+$4.82M
5
AVM
Arch Venture Management
Illinois
+$4.42M

Top Sellers

Rank Fund Capital Flow
1
NM
Newtyn Management
New York
-$851K
2
BCM
BML Capital Management
Indiana
-$230K
3
BlackRock
BlackRock
New York
-$220K
4
GKFF
George Kaiser Family Foundation
Oklahoma
-$186K
5
Renaissance Technologies
Renaissance Technologies
New York
-$106K
Name Holding Trade Value Shares
Change 		Change in
Stake
UBS Group
26
UBS Group
Switzerland
$16K +$2.54K +184 +24%
Morgan Stanley
27
Morgan Stanley
New York
$12.3K -$10K -728 -50%
Wells Fargo
28
Wells Fargo
California
$1.35K -$207 -15 -16%
RhumbLine Advisers
29
RhumbLine Advisers
Massachusetts
$1.11K – – –
Royal Bank of Canada
30
Royal Bank of Canada
Ontario, Canada
$1K +$510 +37 +206%
JP Morgan Chase
31
JP Morgan Chase
New York
$869 -$28 -2 -4%
AF
32
Advisornet Financial
Minnesota
$767 +$620 +45 New
FDCDDQ
33
Federation des caisses Desjardins du Quebec
Quebec, Canada
$665 -$28 -2 -5%
NA
34
NewEdge Advisors
Louisiana
$426 -$14 -1 -4%
Osaic Holdings
35
Osaic Holdings
Arizona
$255 -$14 -1 -6%
BL
36
BFSG LLC
California
$188 – – –
DJSG
37
D.J. St. Germain
Massachusetts
$187 – – –
TIM
38
Thompson Investment Management
Wisconsin
$68 – – –
S
39
Sachetta
Massachusetts
$1 +$14 +1 New
NM
40
Newtyn Management
New York
– -$851K -77,737 Closed
GKFF
41
George Kaiser Family Foundation
Oklahoma
– -$186K -17,029 Closed
Renaissance Technologies
42
Renaissance Technologies
New York
– -$106K -9,700 Closed
State Street
43
State Street
Massachusetts
– -$81.4K -7,434 Closed
Tudor Investment Corp
44
Tudor Investment Corp
Connecticut
– -$70.3K -6,424 Closed
Susquehanna International Group
45
Susquehanna International Group
Pennsylvania
– -$60.2K -5,505 Closed
Northern Trust
46
Northern Trust
Illinois
– -$40K -3,653 Closed
DIM
47
DLK Investment Management
California
– -$36.5K -3,333 Closed
RC
48
RBF Capital
California
– -$35.7K -3,261 Closed
XT
49
XTX Topco
Cayman Islands
– -$33.5K -3,059 Closed
Franklin Resources
50
Franklin Resources
California
– -$24.9K -2,278 Closed
1
2
3

QTTB Hedge Fund Activity: Q1 2024 in Review

39 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Q32 Bio (QTTB) for Q1 2024, worth a combined $126M — up 1,000% from $11.4M a quarter earlier.

Sellers outnumbered buyers: 30 funds closed out of QTTB and 13 opened new positions — a net loss of 17 holders — while 14 trimmed existing stakes and 5 added.

The largest buyer was OrbiMed, opening a new position worth an estimated $31M. The largest seller was Newtyn Management, exiting entirely with an estimated $851K sold.

  • 39 institutional investors held Q32 Bio (QTTB) as of Q1 2024, down from 57 in Q4 2023.
  • Funds reported $126M of Q32 Bio stock for Q1 2024, up 1,000% quarter-over-quarter.
  • 13 funds opened new Q32 Bio positions in Q1 2024 and 30 closed out, a net change of -17 holders.
  • The largest Q32 Bio buyer in Q1 2024 was OrbiMed, an estimated $31M added.
  • The largest Q32 Bio seller in Q1 2024 was Newtyn Management, an estimated $851K sold.

Based on aggregated 13F filings for Q1 2024.